Scarica l'app Stockscreener
154.43
1.49%
-2.33
Dopo l'orario di chiusura:
154.43
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché DVA Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$156.76
Aprire:
$157.01
Volume 24 ore:
574.92K
Relative Volume:
0.55
Capitalizzazione di mercato:
$10.32B
Reddito:
$13.64B
Utile/perdita netta:
$1.05B
Rapporto P/E:
16.16
EPS:
9.555
Flusso di cassa netto:
$1.31B
1 W Prestazione:
+3.43%
1M Prestazione:
-1.20%
6M Prestazione:
+18.07%
1 anno Prestazione:
+1.27%
Intervallo 1D:
$153.83
$157.01
Intervallo di 1 settimana:
$150.71
$157.18
Portata 52W:
$101.00
$159.42
Davita Inc Stock (DVA) Company Profile
Nome
Davita Inc
Settore
Industria
Telefono
310-536-2668
Indirizzo
2000 16TH STREET, DENVER, CO
Compare DVA vs HCA, THC, FMS, ENSG, UHS
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
DVA
Davita Inc
|
154.43 | 10.32B | 13.64B | 1.05B | 1.31B | 9.555 |
HCA
Hca Healthcare Inc
|
471.85 | 105.49B | 75.60B | 7.78B | 7.69B | 28.38 |
THC
Tenet Healthcare Corp
|
191.86 | 16.68B | 21.31B | 2.37B | 2.53B | 15.49 |
FMS
Fresenius Medical Care Ag Adr
|
22.06 | 12.32B | 22.18B | 1.36B | 2.00B | 1.9216 |
ENSG
Ensign Group Inc
|
200.66 | 11.66B | 5.06B | 344.26M | 370.71M | 5.8446 |
UHS
Universal Health Services Inc
|
184.04 | 11.24B | 17.36B | 1.51B | 849.25M | 23.15 |
Davita Inc Stock (DVA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-03-06 | Iniziato | Barclays | Equal Weight |
| 2023-08-07 | Aggiornamento | UBS | Neutral → Buy |
| 2022-11-01 | Downgrade | Deutsche Bank | Buy → Hold |
| 2022-10-31 | Downgrade | UBS | Buy → Neutral |
| 2022-08-19 | Ripresa | UBS | Buy |
| 2022-06-21 | Reiterato | BofA Securities | Underperform |
| 2021-09-10 | Iniziato | Cowen | Market Perform |
| 2021-08-12 | Downgrade | Barclays | Overweight → Equal Weight |
| 2021-03-26 | Downgrade | BofA Securities | Neutral → Underperform |
| 2021-01-05 | Downgrade | BofA Securities | Buy → Neutral |
| 2020-01-24 | Aggiornamento | Goldman | Neutral → Buy |
| 2019-11-07 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2019-10-25 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2019-09-11 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2019-07-26 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2019-01-08 | Aggiornamento | UBS | Sell → Neutral |
| 2019-01-03 | Iniziato | Deutsche Bank | Buy |
| 2018-12-14 | Iniziato | Barclays | Overweight |
| 2018-11-28 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2018-11-16 | Iniziato | UBS | Sell |
| 2018-11-08 | Downgrade | Raymond James | Strong Buy → Mkt Perform |
| 2018-09-13 | Aggiornamento | JP Morgan | Underweight → Neutral |
| 2018-01-04 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2017-12-12 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2017-12-11 | Aggiornamento | Citigroup | Neutral → Buy |
| 2017-12-07 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2017-11-08 | Reiterato | RBC Capital Mkts | Sector Perform |
| 2017-10-09 | Downgrade | JP Morgan | Neutral → Underweight |
| 2017-06-26 | Downgrade | Jefferies | Buy → Hold |
| 2016-12-13 | Downgrade | Robert W. Baird | Outperform → Neutral |
Mostra tutto
Davita Inc Borsa (DVA) Ultime notizie
Assenagon Asset Management Trims DaVita Stake - National Today
Assenagon Asset Management S.A. Trims Holdings in DaVita Inc. $DVA - MarketBeat
DaVita stock dips 1.49% as company promotes home dialysis benefits - Traders Union
Wedge Capital Management L L P NC Purchases 45,998 Shares of DaVita Inc. $DVA - marketbeat.com
SG Americas Securities LLC Increases Stake in DaVita Inc. $DVA - marketbeat.com
DaVita (FRA:TRL) PB Ratio : (As of Mar. 28, 2026) - gurufocus.com
DaVita Inc. stock outperforms competitors despite losses on the day - MarketWatch
Why DaVita Inc (DVA) Is Set to Outperform the Market: Insights i - GuruFocus
DaVita Inc. (NYSE:DVA) Given Consensus Recommendation of "Hold" by Brokerages - MarketBeat
Should Value Investors Buy DaVita (DVA) Stock? - Yahoo Finance
DaVita Inc. stock outperforms competitors on strong trading day - MarketWatch
DaVita tops chart as the only large-cap healthcare services name rated strong buy - msn.com
DaVita Inc. stock faces scrutiny amid dialysis sector reimbursement pressures and Medicare policy sh - AD HOC NEWS
Flexibility of a Home Dialysis Nurse - CSRwire
Nordea Investment Management AB Boosts Holdings in DaVita Inc. $DVA - marketbeat.com
DaVita, Inc. Experiences Revision in Stock Evaluation Amidst Market Dynamics - Markets Mojo
How Investors Are Reacting To DaVita (DVA) CKCC Savings And Value-Based Kidney Care Momentum - Sahm
Hedge Fund Moves: Can DaVita Inc continue delivering strong returnsGap Up & Trade Opportunity Analysis Reports - baoquankhu1.vn
Truist Lowers PT on DaVita Inc. (DVA), Keeps a Hold Rating - MSN
DaVita Stock: Is DVA Outperforming the Health Care Sector? - Yahoo Finance
DaVita Inc Stock (ISIN: US23804L1035) Gains on Value-Based Care Progress Amid Institutional Selling - AD HOC NEWS
DaVita reports progress in value-based kidney care programs By Investing.com - Investing.com Australia
DaVita’s Strong Operations Confront Debt Warning And Insider Selling Signals - Yahoo Finance
DaVita reports progress in value-based kidney care programs - Investing.com
DaVita Highlights Continued Progress in Value-Based Kidney Care as CKCC Results Show Year-Over-Year Improvement - PR Newswire
Chart Watch: Will DaVita Inc stock benefit from M A2026 Big Picture & High Accuracy Swing Entry Alerts - baoquankhu1.vn
Zacks Industry Outlook Features Quest Diagnostics, DaVita, Option Care Health, and Addus HomeCare - Bitget
Zacks Industry Outlook Highlights Quest Diagnostics, DaVita, Option Care Health and Addus HomeCare - Zacks Investment Research
DaVita's kidney care program delivered $200M in savings as quality improved - Stock Titan
DaVita getting closer to key technical benchmark - MSN
DaVita (DVA) Backs R1 Therapeutics with Major Investment - GuruFocus
R1 Therapeutics launches with oversubscribed $77.5 million Series A financing to advance first-in-class treatment for hyperphosphatemia in patients with chronic kidney disease - GlobeNewswire Inc.
Zacks.com featured highlights include Strategic Education, Seanergy Maritime Holdings, DaVita and FirstEnergy - Yahoo Finance
Delta Global Management LP Buys New Holdings in DaVita Inc. $DVA - MarketBeat
DaVita Mixes Strong Value Signals With Distress Score And Insider Selling - sahmcapital.com
DaVita Inc Stock (ISIN: US23804L1035) Faces Headwinds Amid Dialysis Demand Shifts and Regulatory Scr - AD HOC NEWS
DaVita Inc. stock underperforms Monday when compared to competitors - MarketWatch
DaVita Inc. Trade Ideas — LS:897914 - TradingView
DaVita Stock Sits at $151 With Analysts Pointing to a $190 High Target - TIKR.com
DaVita Stock Forms Golden Cross, Signaling Potential Bullish Breakout Ahead - Markets Mojo
DaVita Inc. $DVA Shares Acquired by Doma Perpetual Capital Management LLC - MarketBeat
Aquatic Capital Management Boosts Stake in DaVita - National Today
Aquatic Capital Management LLC Acquires 40,333 Shares of DaVita Inc. $DVA - MarketBeat
DaVita Inc. $DVA Shares Sold by Berkshire Hathaway Inc - MarketBeat
Is DaVita (DVA) Pricing Reflect Its Strong Multi‑Year Share Performance And Cash Flow Outlook - simplywall.st
DVA (DaVita) Graham Number : $N/A (As of Dec. 2025) - GuruFocus
DaVita (DVA) and Jazz Pharmaceuticals (JAZZ) Lead with Strong Bu - GuruFocus
DaVita Inc Stock (ISIN: US23804L1035) Gains Momentum on Institutional Buying and Strong Guidance - AD HOC NEWS
Jim Cramer on DaVita: "Haven’t seen that stock do that well in this long" - MSN
DaVita Inc. stock underperforms Friday when compared to competitors - MarketWatch
DaVita, Inc. Experiences Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo
Davita Inc Azioni (DVA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.17%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):